Skip to main content
Log in

The effects of cilazapril and valsartan on the mRNA and protein expressions of atrial calpains and atrial structural remodeling in atrial fibrillation dogs

  • ORIGINAL CONTRIBUTION
  • Published:
Basic Research in Cardiology Aims and scope Submit manuscript

Abstract

Owing to relative inefficacy and side effects of currently available antiarrhythmic drugs, current interest has shifted to treatments that target atrial fibrillation (AF) substrate. It has been suggested that calpain-induced atrial structural remodelling is under the control of renin-angiotensin system during AF. The purpose of this study is to investigate the effects of cilazapril and valsartan on the mRNA and protein expression of atrial calpains and atrial structural remodelling in AF dogs induced by chronic rapid atrial pacing. Twenty-seven dogs were randomly divided into sham-operated group (n = 6), control group (n = 7), cilazapril group (n = 7) and valsartan group (n = 7). One thin silicon plaque containing 4 pairs of electrodes was sutured to each atrium. A pacemaker was implanted in a subcutaneous pocket and attached to a screw-in epicardial lead in the right atrial appendage. The dogs in control group, cilazapril group and valsartan group were paced at 400 beats per minutes for 6 weeks. The dogs in cilazapril and valsartan groups received cilazapril (1mg · kg· d) or valsartan (30mg · kg· d) 1 week before rapid atrial pacing until pacing stop respectively. Transthoracic and transoesophageal echocardiographic examinations were performed in order to detect the changes of left atrium volume and contractile function. The inducibility and duration of AF were measured in all the groups. The expressions of atrial calpain I and calpain II mRNA were semi-quantified by reverse transcription-polymerase chain reaction. The protein levels of calpain I and calpain II in atrial myocardium were measured by Western-blot method. Pathohistological and ultrastructural changes in atrial tissue were tested by light and electron microscopy. Compared with the sham-operated control group, dramatic smaller left atrium and left atrial appendage volumes and significant higher atrial contractile function were observed in the cilazapril and valsartan groups. After 6-week atrial tachy-pacing, the mRNA and protein expressions of calpain I increased dramatically in the control group than that in the sham group, tissue calpain protein expression in all groups significantly correlated with the myolysis (r = 0.89, P < 0.01). Cilazapril and valsartan could significantly inhibit the gene and protein expressions of calpain I. No differences were found in the expression of calpain II mRNA and protein between the groups. Compared with atrial myocytes obtained from sham dogs, atrial myocytes from the control group dogs showed a reduced number of sarcomeres, a significant higher myolytic area of atria (24.3% vs. 3.1%, P < 0.01), increased vacuolization and dissolution. Cilazapril and valsartan could effectively prevent the pathohistological and ultrastructural changes induced by chronic rapid atrial pacing, dramatically decrease the area of myolysis (P < 0.05) and significantly reduce the inducibility and duration of AF. The expression of calpain I mRNA and protein increased remarkably in AF dogs. Cilazapril and valsartan can inhibit calpain I up-regulation, suppress atrial structural remodeling, and prevent the induction and promotion of AF in chronic rapid atrial pacing dogs.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Aime-Sempe C, Folliguet T, Rucker- Martin C, Krajewska M, Krajewska S, Heimburger M, Aubier M, Mercadier JJ, Reed JC, Hatem SN (1999) Myocardial cell death in fibrillating and dilated human right atria. J Am Coll Cardiol 34:1577–1586

    Article  CAS  PubMed  Google Scholar 

  2. Ak K, Akgun S, Tecimer T, Isbir CS, Civelek A, Tekeli A, Arsan S, Cobanoglu A (2005) Determination of histopathologic risk factors for postoperative atrial fibrillation in cardiac surgery. Ann Thorac Surg 79:1970–1975

    Article  PubMed  Google Scholar 

  3. Allessie M, Ausma J, Schotten U (2002) Electrical, contractile and structural remodeling during atrial fibrillation. Cardiovasc Res 54:230–246

    Article  CAS  PubMed  Google Scholar 

  4. Ausma J, Van der Velden H, Lenders MH, Duimel H, Borgers M, Allessie MA (2001) Partial recovery from structural atrial remodeling after prolonged atrial fibrillation. Circulation 104 (Suppl II):II/77

    Google Scholar 

  5. Ausma J, Wijffels M, Thone F, Wouters L, Allessie M, Borgers M (1997) Structural changes of atrial myocardium due to sustained atrial fibrillation in the goat. Circulation 96:3157–3163

    CAS  PubMed  Google Scholar 

  6. Brundel BJ, Ausma J, van Gelder IC, Van der Want JJ, van Gilst WH, Crijns HJ, Henning RH (2002) Activation of proteolysis by calpains and structural changes in human paroxysmal and persistent atrial fibrillation. Cardiovasc Res 54:315–324

    Article  CAS  PubMed  Google Scholar 

  7. Brundel BJ, Kampinga HH, Henning RH (2004) Calpain inhibition prevents pacing-induced cellular remodeling in a HL-1 myocyte model for atrial fibrillation. Cardiovasc Res 62:521–328

    Article  CAS  PubMed  Google Scholar 

  8. Contard F, Koteliansky V, Marotte F, Dubus I, Rappaport L, Samuel JL (1991) Specific alterations in the distribution of extracellular matrix components within rat myocardium during the development of pressure overload. Lab Invest 64:65–75

    CAS  PubMed  Google Scholar 

  9. Dai Y, Wang X, Cao L, Wu T (2004) Expression of extracellular signal-regulated kinase and angiotensin-converting enzyme in human atria during atrial fibrillation. J Huazhong Univ Sci Technolog Med Sci 24:32–36

    Article  CAS  PubMed  Google Scholar 

  10. Everett TH 4th, Li H, Mangrum JM, McRury ID, Mitchell MA, Redick JA, Haines DE (2000) Electrical, morphological, and ultrastructural remodeling and reverse remodeling in a canine model of chronic atrial fibrillation. Circulation 102:1454–1460

    PubMed  Google Scholar 

  11. Fogari R, Mugellini A, Destro M, Corradi L, Zoppi A, Fogari E, Rinaldi A (2006) Losartan and prevention of atrial fibrillation recurrence in hypertensive patients. J Cardiovasc Pharmacol 47:46–50

    Article  CAS  PubMed  Google Scholar 

  12. Frustaci A, Chimenti C, Bellocci F, Morgante E, Russo MA, Maseri A (1997) Histological substrate of atrial biopsies in patients with lone atrial fibrillation. Circulation 96:1180–1184

    CAS  PubMed  Google Scholar 

  13. Gil-Parrado S, Fernandez-Montalvan A, Assfalg-Machleidt I, Popp O, Bestvater F, Holloschi A, Knoch TA, Auerswald EA, Welsh K, Reed JC, Fritz H, Fuentes- Prior P, Spiess E, Salvesen GS, Machleidt W (2002) Ionomycin-activated calpain triggers apoptosis. A probable role for Bcl-2 family members. J Biol Chem 227:27217–27226

    Article  CAS  Google Scholar 

  14. Godtfredsen J (1975) Atrial fibrillation Etiology, Course and Prognosis. A Follow- up Study of 1212 Cases. Copenhagen: University of Copenhagen

  15. Goette A, Arndt M, Rocken C, Staack T, Bechtloff R, Reinhold D, Huth C, Ansorge S, Klein HU, Lendeckel U (2002) Calpains and cytokines in fibrillating human atria. Am J Physiol Heart Circ Physiol 283:H264–H272

    CAS  PubMed  Google Scholar 

  16. Grishko V, Pastukh V, Solodushko V, Gillespie M, Azuma J, Schaffer S (2003) Apoptotic cascade initiated by angiotensin II in neonatal cardiomyocytes: role of DNA damage. Am J Physiol Heart Circ Physiol 285:H2364–H2372

    CAS  PubMed  Google Scholar 

  17. Hirayama Y, Atarashi H, Kobayashi Y, Horie T, Iwasaki Y, Maruyama M, Miyauchi Y, Ohara T, Yashima M, Takano T (2005) Angiotensin-converting enzyme inhibitor therapy inhibits the progression from paroxysmal atrial fibrillation to chronic atrial fibrillation. Circ J 69:671–676

    Article  CAS  PubMed  Google Scholar 

  18. Kinebuchi O, Mitamura H, Shiroshita-Takeshita A, Kurita Y, Ieda M, Ohashi N, Fukuda Y, Sato T, Miyoshi S, Hara M, Takatsuki S, Nagumo M, Ogawa S (2004) Oral verapamil attenuates the progression of pacing-induced electrical and mechanical remodeling of the atrium. Circ J 68:494–500

    Article  CAS  PubMed  Google Scholar 

  19. Kossmehl P, Kurth E, Faramarzi S, Habighorst B, Shakibaei M, Wehland M, Kreutz R, Infanger M, J Danser AH, Grosse J, Paul M, Grimm D (2006) Mechanisms of apoptosis after ischemia and reperfusion: role of the renin-angiotensin system. Apoptosis 11:347–358

    Article  CAS  PubMed  Google Scholar 

  20. Li Y, Li WM, Xue JY, Han W, Yang SS, Gu HY (2004) An experimental study on the effects of cilazapril on atrial remodeling in atrial fibrillation dogs. Zhonghua Xin Xue Guan Bing Za Zhi 32:1033

    Google Scholar 

  21. Lukkarinen HP, Laine J, Aho H, Zagariya A, Vidyasagar D, Kaapa PO (2005) Angiotensin II receptor inhibition prevents pneumocyte apoptosis in surfactant-depleted rat lungs. Pediatr Pulmonol 39:349–358

    Article  PubMed  Google Scholar 

  22. Manning WJ, Silverman DI, Katz SE, Riley MF, Doherty RM, Munson JT, Douglas PS (1995) Temporal dependence of the return of atrial mechanical function on the mode of cardioversion of atrial fibrillation to sinus rhythm. Am J Cardiol 75:624–626

    Article  CAS  PubMed  Google Scholar 

  23. Nakashima H, Kumagai K, Urata H, Gondo N, Ideishi M, Arakawa K (2000) Angiotensin II antagonist prevents electrical remodeling in atrial fibrillation. Circulation 101:2612–2617

    CAS  PubMed  Google Scholar 

  24. Pedersen OD, Bagger H, Kober L, Torp-Pedersen C (1999) Trandolapril reduces the incidence of atrial fibrillation after acute myocardial infarction in patients with left ventricular dysfunction. Circulation 100:376–380

    CAS  PubMed  Google Scholar 

  25. Sandmann S, Yu M, Unger T (2001) Transcriptional and translational regulation of calpain in the rat heart after myocardial infarction — effects of AT(1) and AT(2) receptor antagonists and ACE inhibitor. Br J Pharmacol 132:767–777

    Article  CAS  PubMed  Google Scholar 

  26. Schotten U, Ausma J, Stellbrink C, Sabatschus I, Vogel M, Frechen D, Schoendube F, Hanrath P, Allessie MA (2001) Cellular mechanisms of depressed atrial contractility in patients with chronic atrial fibrillation. Circulation 103:691–698

    CAS  PubMed  Google Scholar 

  27. Schotten U, de Haan S, Neuberger HR, Eijsbouts S, Blaauw Y, Tieleman R, Allessie M (2004) Loss of atrial contractility is primary cause of atrial dilatation during first days of atrial fibrillation. Am J Physiol Heart Circ Physiol 5:H2324–H2331

    Article  CAS  Google Scholar 

  28. Sharma AK, Rohrer B (2004) Calciuminduced calpain mediates apoptosis via caspase-3 in a mouse photoreceptor cell line. J Biol Chem 279:35564–35572

    Article  CAS  PubMed  Google Scholar 

  29. Shi Y, Ducharme A, Li D, Gaspo R, Nattel S, Tardif JC (2001) Remodeling of atrial dimensions and emptying function in canine models of atrial fibrillation. Cardiovasc Res 52:217–225

    Article  CAS  PubMed  Google Scholar 

  30. Thijssen VL, Ausma J, Liu GS, Allessie MA, van Eys GJ, Borgers M (2000) Structural changes of atrial myocardium during chronic atrial fibrillation. Cardiovasc Pathol 9:17–28

    Article  CAS  PubMed  Google Scholar 

  31. Touyz RM, Sventek P, Lariviere R, Thibault G, Fareh J, Reudelhuber T, Schiffrin EL (1996) Cytosolic calcium changes induced by angiotensin II in neonatal rat atrial and ventricular cardiomyocytes are mediated via angiotensin II subtype 1 receptors. Hypertension 27:1090–1096

    CAS  PubMed  Google Scholar 

  32. Wang KK (2000) Calpain and caspase: can you tell the difference? Trends Neurosci 23:20–26

    Article  PubMed  Google Scholar 

  33. Willems R, Sipido KR, Holemans P, Ector H, Van de Werf F, Heidbuchel H (2001) Different patterns of angiotensin II and atrial natriuretic peptide secretion in a sheep model of atrial fibrillation. J Cardiovasc Electrophysiol 12:1387–1392

    Article  CAS  PubMed  Google Scholar 

  34. Yue L, Feng J, Gaspo R, Li GR,Wang Z, Nattel S (1997) Ionic remodeling underlying action potential changes in a canine model of atrial fibrillation. Circ Res 81:512–525

    CAS  PubMed  Google Scholar 

  35. Yu WC, Lee SH, Tai CT, Tsai CF, Hsieh MH, Chen CC, Ding YA, Chang MS, Chen SA (1999) Reversal of atrial electrical remodeling following cardioversion of long-standing atrial fibrillation in man. Cardiovasc Res 42:470–476

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to B. Yang.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Li, Y., Li, W., Gong, Y. et al. The effects of cilazapril and valsartan on the mRNA and protein expressions of atrial calpains and atrial structural remodeling in atrial fibrillation dogs. Basic Res Cardiol 102, 245–256 (2007). https://doi.org/10.1007/s00395-007-0641-8

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00395-007-0641-8

Key words

Navigation